The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination
- 31 October 2007
- journal article
- editorial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 197 (4) , 337-339
- https://doi.org/10.1016/j.ajog.2007.08.030
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsPublished by Elsevier ,2007
- 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situAmerican Journal of Obstetrics and Gynecology, 2007
- Cervical Cancer Screening Following the Implementation of Prophylactic Human Papillomavirus VaccinationFuture Oncology, 2007
- Human Papillomavirus Vaccine: A New Chance to Prevent Cervical CancerPublished by Springer Nature ,2006
- Will Widespread Human Papillomavirus Prophylactic Vaccination Change Sexual Practices of Adolescent and Young Adult Women in America?Obstetrics & Gynecology, 2006
- Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and ChallengesThe Oncologist, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the USPharmacoEconomics, 2005
- Cervical cancer screeningCurrent Oncology Reports, 2004
- Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lostInternational Journal of Cancer, 2004